SLC4A1 and COVID-19: More specifically, the authors of this investigation found that circulating erythrocytes of COVID-19 patients displayed substantially enhanced expression of glycolytic intermediates, combined with significant degree of oxidative damages and consequent fragmentation of proteins such as spectrin beta, ankyrin, and N-terminal cytosolic domain of band 3 (AE1).